Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Determinants of hospital costs in community acquired pneumonia

Burcu Karaboga, Ugur Bilge, Aykut Cilli
European Respiratory Journal 2012 40: P2556; DOI:
Burcu Karaboga
1Chest Diseases, Akdeniz University Medical School, Antalya, Konyaalti, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ugur Bilge
2Biostatistics and Master of Science Branch of Medical Informatics, Akdeniz University Medical School, Antalya, Konyaalti, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aykut Cilli
1Chest Diseases, Akdeniz University Medical School, Antalya, Konyaalti, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Community-acquired pneumonia (CAP) is a prevalent disease and constitutes a substantial socio-economic burden. On the other hand, there is limited data about the cost of CAP in Turkey.

This study investigated direct costs and related factors for hospitalised CAP patients. Direct hospitalisation costs and possible associated factors (age, sex, comorbidity, clinical and laboratory findings, smoking history, antibiotic usage within 3 months, length of hospital stay, ICU stay, PSI, CURB65, treatment success and medication groups such as antibiotics, steroids, immunosupressives) were assessed in a retrospective study of 106 patients admitted to a hospital ward due to CAP.The mean patient age was 60.4 yrs and 35.8% were female. Comorbidities were found in 87% and the most significiant comorbidities were DM, CAD and COPD. Eight (7.5%) patients needed ICU care. Overall CAP treatment success rate was 89.6%. Length of hospital stay (p=0.001, r= 0.78), use of antipseudomonal antibiotic combination (p=0.001), use of antibiotic within 3 months (p=0.001) and two or more hospitalisation days within 3 months (p=0.031) increased the costs but age, comorbidity, treatment success, ICU requirement, PSI and CURB65 scores did not increase the costs. In conclusion, this study provides cost estimates for the treatment of patients hospitalised with CAP. Major determinants of costs were length of hospital stay, use of antipseudomonal antibiotic combination, use of antibiotic within 3 months and two or more hospitalisation days within 3 months.

  • Pneumonia
  • Sepsis
  • Treatments
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determinants of hospital costs in community acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Determinants of hospital costs in community acquired pneumonia
Burcu Karaboga, Ugur Bilge, Aykut Cilli
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2556;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Determinants of hospital costs in community acquired pneumonia
Burcu Karaboga, Ugur Bilge, Aykut Cilli
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2556;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The implementation of IDSA/ATS and the Greek national guidelines for CAP by chest physicians in Greece
  • Pneumolysin mediates platelet activation in vitro
  • Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society